BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10607589)

  • 1. Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin.
    Dumler I; Stepanova V; Jerke U; Mayboroda OA; Vogel F; Bouvet P; Tkachuk V; Haller H; Gulba DC
    Curr Biol; 1999 Dec 16-30; 9(24):1468-76. PubMed ID: 10607589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-dependent human vascular smooth muscle cell adhesion requires selective vitronectin phosphorylation by ectoprotein kinase CK2.
    Stepanova V; Jerke U; Sagach V; Lindschau C; Dietz R; Haller H; Dumler I
    J Biol Chem; 2002 Mar; 277(12):10265-72. PubMed ID: 11756447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.
    Lugano R; Peña E; Badimon L; Padró T
    J Thromb Haemost; 2012 Oct; 10(10):2158-67. PubMed ID: 22906080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells.
    Padró T; Mesters RM; Dankbar B; Hintelmann H; Bieker R; Kiehl M; Berdel WE; Kienast J
    J Cell Sci; 2002 May; 115(Pt 9):1961-71. PubMed ID: 11956327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms.
    Stepanova V; Mukhina S; Köhler E; Resink TJ; Erne P; Tkachuk VA
    Mol Cell Biochem; 1999 May; 195(1-2):199-206. PubMed ID: 10395084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes.
    Chavakis T; Kanse SM; Yutzy B; Lijnen HR; Preissner KT
    Blood; 1998 Apr; 91(7):2305-12. PubMed ID: 9516128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells.
    Tang H; Kerins DM; Hao Q; Inagami T; Vaughan DE
    J Biol Chem; 1998 Jul; 273(29):18268-72. PubMed ID: 9660790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
    Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
    J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.
    Tran H; Maurer F; Nagamine Y
    Mol Cell Biol; 2003 Oct; 23(20):7177-88. PubMed ID: 14517288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells.
    Busso N; Masur SK; Lazega D; Waxman S; Ossowski L
    J Cell Biol; 1994 Jul; 126(1):259-70. PubMed ID: 7517943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells.
    Dumler I; Weis A; Mayboroda OA; Maasch C; Jerke U; Haller H; Gulba DC
    J Biol Chem; 1998 Jan; 273(1):315-21. PubMed ID: 9417082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
    Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
    Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator.
    Kindzelskii AL; Amhad I; Keller D; Zhou MJ; Haugland RP; Garni-Wagner BA; Gyetko MR; Todd RF; Petty HR
    Histochem Cell Biol; 2004 Apr; 121(4):299-310. PubMed ID: 15042374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
    Jo M; Thomas KS; Marozkina N; Amin TJ; Silva CM; Parsons SJ; Gonias SL
    J Biol Chem; 2005 Apr; 280(17):17449-57. PubMed ID: 15728176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
    Yebra M; Goretzki L; Pfeifer M; Mueller BM
    Exp Cell Res; 1999 Jul; 250(1):231-40. PubMed ID: 10388537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.
    Tarui T; Andronicos N; Czekay RP; Mazar AP; Bdeir K; Parry GC; Kuo A; Loskutoff DJ; Cines DB; Takada Y
    J Biol Chem; 2003 Aug; 278(32):29863-72. PubMed ID: 12754207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
    Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
    Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.
    Conese M; Nykjaer A; Petersen CM; Cremona O; Pardi R; Andreasen PA; Gliemann J; Christensen EI; Blasi F
    J Cell Biol; 1995 Dec; 131(6 Pt 1):1609-22. PubMed ID: 8522616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
    Kiyan J; Haller H; Dumler I
    Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular distribution of urokinase and urokinase receptor in human neutrophils determined by immunoelectron microscopy.
    Pedersen TL; Plesner T; Horn T; Høyer-Hansen G; Sørensen S; Hansen NE
    Ultrastruct Pathol; 2000; 24(3):175-82. PubMed ID: 10914429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.